We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Novartis AG | NYSE:NVS | NYSE | Depository Receipt |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 1.13 | 1.16% | 98.86 | 99.19 | 98.54 | 98.60 | 1,159,818 | 00:50:51 |
From May 2019 to May 2024
ZURICH—-Novartis AG said on Wednesday that its fourth-quarter net profit fell 57% compared with the corresponding period a year earlier as the Swiss drug giant's eye-care unit dragged on performance.
Basel-based Novartis said net income fell to $1.05 billion in the quarter ended in December, compared with $2.45 billion in the same period a year earlier.
Revenue dipped 4% to $12.52 billion, the company said. Core net income, which strips out one-time events such as impairments or gains, fell to $2.7 billion from $2.9 billion a year earlier, Novartis said.
Analysts had expected revenue of $12.7 billion and core net income of $2.7 billion.
Write to John Letzing at john.letzing@wsj.com and Denise Roland at Denise.Roland@wsj.com
(END) Dow Jones Newswires
January 27, 2016 02:35 ET (07:35 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
1 Year Novartis Chart |
1 Month Novartis Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
